NCB Injectable Biomatrix

North Brabant, Netherlands

Short Summary

NC Biomatrix’s innovation is a minimally invasive therapy (injection) that restores biomechanics of the spine. This means that it directly acts at the source of the back pain. Its functionality has been proven in cellular, organ and animal studies

Overview

Target
250,000€
Minimum
25,000€
Investment Raised
N/A
Previous Rounds N/A
Stage MVP/Finished Product
Investor Role Monthly Involvement

Highlights

  • 2 PCT patents, one already in the regional phase
  • Truely innovative treatment option for back pain caused by disc degenerati
  • Highly experienced and compentent management team
  • Strong partners in all key areas - mfg., regulatory, testing and clinical
  • Massive opportunity with 11 million potential patients in the EU alone
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Pro
40% raised

Anti Surgical Adhesions

location_on Gelderland, Netherlands

EIO Biomedical has developed the first biochemically active solution to prevent surgical adhesions which cause 35% surgery rates, 20% of all female infertility cases, and chronic pain. We seek to launch a KOL clinical trial in 8 centres in Holland.

2,500,000 €

Target

250,000 €

Min per Investor

Pro
0% raised

AI Cancer Detection

location_on North Holland, Netherlands

WSK Medical is an innovative software company focused exclusively on developing leading-edge machine learning applications for the medical field. We are focused on cancerous diseases and are working together with leading institutions and specialists.

500,000 €

Target

100,000 €

Min per Investor

Global Pro
18% raised

Inhalable cannabis & CBD

location_on London, United Kingdom

hapac® is a unique patent pending system for vaporising medical cannabis and CBD. It also has the potential to be the lowest-cost cannabis product in the market due to its high-speed automated production and low variable costs.

910,000 €

Target

22,000 €

Min per Investor

load one similar proposal